Maximus Inc. (NYSE:MMS) has earned a consensus recommendation of “Buy” from the ten brokerages that are covering the stock. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $65.75.

Several equities analysts have weighed in on the company. Maxim Group lifted their price objective on Maximus from $71.00 to $74.00 and gave the company a “buy” rating in a report on Thursday, August 4th. KeyCorp assumed coverage on Maximus in a report on Monday, July 11th. They issued a “buy” rating for the company. Finally, Zacks Investment Research cut Maximus from a “hold” rating to a “sell” rating in a report on Wednesday, August 3rd.

In related news, Director Paul R. Lederer sold 500 shares of the business’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $59.15, for a total transaction of $29,575.00. Following the sale, the director now owns 74,674 shares in the company, valued at approximately $4,416,967.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Bruce Caswell sold 30,000 shares of the business’s stock in a transaction on Thursday, August 18th. The stock was sold at an average price of $58.98, for a total value of $1,769,400.00. Following the sale, the president now owns 39,386 shares in the company, valued at approximately $2,322,986.28. The disclosure for this sale can be found here. Corporate insiders own 3.60% of the company’s stock.

Large investors have recently modified their holdings of the company. FMR LLC raised its stake in shares of Maximus by 17.4% in the second quarter. FMR LLC now owns 5,269,547 shares of the company’s stock worth $291,775,000 after buying an additional 780,765 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Maximus by 67.5% in the first quarter. Goldman Sachs Group Inc. now owns 1,211,350 shares of the company’s stock worth $63,765,000 after buying an additional 488,027 shares during the period. FIL Ltd raised its stake in Maximus by 171.8% in the second quarter. FIL Ltd now owns 716,824 shares of the company’s stock worth $39,690,000 after buying an additional 453,116 shares during the period. Makaira Partners LLC bought a new stake in Maximus during the first quarter worth approximately $23,251,000. Finally, Emerald Acquisition Ltd. bought a new stake in Maximus during the second quarter worth approximately $21,558,000. Institutional investors and hedge funds own 99.00% of the company’s stock.

Shares of Maximus (NYSE:MMS) traded down 1.12% during trading on Thursday, hitting $54.96. The stock had a trading volume of 150,116 shares. The stock has a market capitalization of $3.57 billion, a price-to-earnings ratio of 22.46 and a beta of 1.15. The stock has a 50 day moving average price of $57.63 and a 200-day moving average price of $55.77. Maximus has a one year low of $45.15 and a one year high of $69.85.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 4th. The company reported $0.75 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.04. The firm earned $617.10 million during the quarter, compared to analysts’ expectations of $625.62 million. Maximus had a return on equity of 23.89% and a net margin of 6.91%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.62 EPS. On average, equities research analysts predict that Maximus will post $2.65 earnings per share for the current year.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.

5 Day Chart for NYSE:MMS

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.